These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4380496)

  • 21. beta- and alpha-Adrenoceptor antagonism by medroxalol in healthy volunteers: relationship to dose and plasma concentration.
    Jaillon P; Weissenburger J; Biour M; Cheymol G; Haegele K; Schechter PJ; Koch-Weser J
    J Cardiovasc Pharmacol; 1982; 4(5):705-13. PubMed ID: 6182399
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical experimentation with a new sympathomimetic amine, dimetophrine (SM 14), in pediatric anesthesia and resuscitation].
    Pallecchi AE; Marino C; Silvestri G
    Minerva Anestesiol; 1972 May; 38(5):284-96. PubMed ID: 4603100
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of isopropylamino radical on the cardiovascular system.
    Toyama S; Amemiya T; Suzuki K
    Jpn Circ J; 1968 Mar; 32(3):341-6. PubMed ID: 4386275
    [No Abstract]   [Full Text] [Related]  

  • 24. Effectiveness of low dose denopamine, a beta1-adrenoceptor agonist, in a patient with vasospastic angina refractory to intensive medical treatment.
    Nakajima D; Negoro N; Nakaboh A; Nakakoji T; Hoshiga M; Nariyama J; Ishihara T; Hanafusa T
    Int J Cardiol; 2006 Apr; 108(2):281-3. PubMed ID: 15913812
    [No Abstract]   [Full Text] [Related]  

  • 25. Renal haemodynamics after chronic treatment with labetalol and propranolol.
    Malini PL; Strocchi E; Negroni S; Ambrosioni E; Magnani B
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):123S-126S. PubMed ID: 7093095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further observations on the possible role of noradrenaline in centrally mediated cardiovascular responses.
    Gagnon DJ; Melville KI
    Rev Can Biol; 1966 Jun; 25(2):99-105. PubMed ID: 4381427
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of fenoterol on blood pressure, heart rate, and cardiotocogram of hypertensive and normotensive women in advanced pregnancy (author's transl)].
    Oddoy A; Joschko K
    Zentralbl Gynakol; 1982; 104(7):415-21. PubMed ID: 7102159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nebivolol versus enalapril in essential hypertension: a long-term double-blind comparative trial.
    Van Nueten L; Rishøj Nielsen M; Vertommen C; Dupont AG; Robertson JI
    Acta Clin Belg; 1999; 54(1):19-25. PubMed ID: 10192973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of pronethalol on the cardiovascular actions of catecholamines during blockade by phenoxybenzamine.
    Garrett J; Malafaya-Baptista A; Osswald W
    Br J Pharmacol Chemother; 1966 Sep; 27(3):459-67. PubMed ID: 4381965
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hemodynamic changes induced with a sympathomimetic amine: dimethophrine].
    Cortinovis A; Crippa A; Sommo F
    Minerva Cardioangiol; 1975; 23(6-7):403-5. PubMed ID: 1170524
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiovascular and antiarrhythmic effects of 1-(4,5-dichloro-2-thienyl)-2-t-butylaminoethanol (QM-5119), a new beta-adrenergic blocking agent.
    Darias V; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1756-9. PubMed ID: 4155633
    [No Abstract]   [Full Text] [Related]  

  • 32. A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients.
    Molimard M; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():28-34. PubMed ID: 15915010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the pharmacology of guanoxan.
    Vidal-Beretervide K; Pritsch LE; Trinidad H
    Arzneimittelforschung; 1969 Jun; 19(6):947-51. PubMed ID: 4389903
    [No Abstract]   [Full Text] [Related]  

  • 34. Action of bricanyl (Terbutaline) on ventilatory capacity in patients with asthma.
    Maranetra N; Pain MC
    Med J Aust; 1973 May; 1(20):988-90. PubMed ID: 4716586
    [No Abstract]   [Full Text] [Related]  

  • 35. Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.
    Lund-Johansen P; Bakke OM
    Br J Clin Pharmacol; 1979 Feb; 7(2):169-74. PubMed ID: 760749
    [No Abstract]   [Full Text] [Related]  

  • 36. Alteration of centrally mediated cardiovascular manifestations by intraventricular pronethalol and phentolamine.
    Gagnon DJ; Melville KI
    Int J Neuropharmacol; 1969 Dec; 8(6):587-92. PubMed ID: 4391345
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of alpha, beta blocker, labetol on the angiotensin renin system in arterial hypertension].
    Sánchez Torres G; Posadas C; Garcia Lara L; Suresh J; Serrano P
    Arch Inst Cardiol Mex; 1978; 48(3):549-61. PubMed ID: 358932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nebivolol: comparison of the effects of dl-nebivolol, d-nebivolol, l-nebivolol, atenolol, and placebo on exercise-induced increases in heart rate and systolic blood pressure.
    Van Nueten L; De Crée J
    Cardiovasc Drugs Ther; 1998 Sep; 12(4):339-44. PubMed ID: 9825177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proceedings: Preliminary studies of Ro 3-3528, a beta-adrenoceptor-blocking agent, in man.
    Hicks DC; Phillips EM
    Br J Pharmacol; 1972 Feb; 44(2):377P-378P. PubMed ID: 4148922
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.